ONO PHARMACEUT./ JP3197600004 /
6/10/2024 8:00:08 AM | Chg. -0.200 | Volume | Bid12:03:52 PM | Ask12:03:52 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
13.100EUR | -1.50% | 0 Turnover: 0.000 |
13.100Bid Size: 231 | 13.500Ask Size: 222 | 7.44 bill.EUR | - | - |
Assets
|
2021 IFRS in mill. JPY |
2022 IFRS in mill. JPY |
|||
---|---|---|---|---|---|
Property and Equipment | 112,131 | 108,420 | |||
Intangible Assets | 64,734 | 69,134 | |||
Long-Term Investments | 125,154 | 123,423 | |||
Fixed Assets | 457,937 | 537,336 | |||
Inventories | 41,817 | 44,814 | |||
Accounts Receivable | 99,788 | 114,396 | |||
Cash and Cash Equivalents | 69,112 | 96,135 | |||
Current Assets | 281,266 | 345,101 | |||
Total Assets | 739,203 | 882,437 |
Liabilities
|
2021 IFRS in mill. JPY |
2022 IFRS in mill. JPY |
|||
---|---|---|---|---|---|
Accounts Payable | 49,689 | 66,794 | |||
Long-term debt | - | - | |||
Liabilities to Banks | - | - | |||
Provisions | 1,009 | 983 | |||
Liabilities | 77,529 | 134,625 | |||
Share Capital | - | - | |||
Total Equity | 655,906 | 741,869 | |||
Minority Interests | 5,768 | 5,944 | |||
Total liabilities equity | 739,203 | 882,437 |
Income Statement
|
2021 IFRS in mill. JPY |
2022 IFRS in mill. JPY |
|||
---|---|---|---|---|---|
Revenues | 361,361 | 447,187 | |||
Depreciation (total) | - | - | |||
Operating Result | 103,195 | 141,963 | |||
Interest Income | 1,836 | 1,565 | |||
Income Before Taxes | - | - | |||
Income Taxes | 24,340 | 30,619 | |||
Minority Interests Profit | -166 | -190 | |||
Net Income | 80,519 | 112,721 |
Per Share
Cash Flow
|
2021 IFRS in mill. JPY |
2022 IFRS in mill. JPY |
|||
---|---|---|---|---|---|
Cash Flow from Operating Activities | 61,829 | 159,610 | |||
Cash Flow from Investing Activities | 6,038 | -100,259 | |||
Cash Flow from Financing | -60,237 | -32,484 | |||
Decrease / Increase in Cash | - | - | |||
Employees | 3,687 | 3,700 |